Company intelligence / Profile preview
New York Blood Center
New York City, New York, USAnybc.org ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
New York Blood Center provides essential blood products to over 500 hospitals nationwide and has pioneered programs such as convalescent plasma collection during the COVID‑19 pandemic. It also operates advanced laboratories focused on precision genomics testing to improve transfusion outcomes.
- Therapeutic areas
- Infectious DiseasesHematology
- Modalities
- Biologic (blood products)Cell therapy (stem cell services)Plasma therapy (convalescent plasma for infectious diseases)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Mayo Clinic (COVID convalescent plasma research validation)Various hospital systems (>500 served nationally)
Beyond the preview
Go deeper on New York Blood Center.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on New York Blood Center.